JLL Partners To Buy BioClinica By: MarketMinute.com Stock News January 30, 2013 at 16:45 PM EST JLL Partners will pay a premium of approximately $123 million in cash to acquire BioClinica Inc. (Nasdaq: BIOC) lifting the stock price $1.17 to close at $7.21.